Enterprise Value
68.37M
Cash
23.24M
Avg Qtr Burn
-1.795M
Short % of Float
1.73%
Insider Ownership
5.06%
Institutional Own.
16.57%
Qtr Updated
04/30/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CAR-T therapy (CER-T) Details Cancer, Ovarian cancer | Phase 1 Data readout | |
Breast Cancer Vaccine Details Breast cancer | Phase 1a Data readout |